Skip to main content
. 2020 Jun 16;123(5):844–851. doi: 10.1038/s41416-020-0939-y

Table 1.

Baseline characteristics of participants by use of proton pump inhibitors.

Characteristica Nurses’ Health Study (2000)
Nurses’ Health Study II (2001)
Health Professionals Follow-Up Study (2004)
Non-users (n = 141,809) Users (n = 9368) Non-users (n = 20,845) Users (n = 3837)
Age (years)b 56 (11) 57 (11) 69 (9) 70 (9)
Body mass index (kg/m2) 25 (5) 27 (6) 26 (3) 26 (3)
Activity (MET-h/week) 19 (19) 16 (16) 35 (28) 32 (26)
Total folate intake (µg/day) 462 (212) 458 (205) 609 (231) 623 (233)
Total vitamin D (IU/day) 372 (201) 377 (198) 446 (228) 461 (234)
Total calcium intake (mg/day) 1058 (388) 1081 (403) 969 (339) 992 (355)
Total fat (g/day) 60 (10) 60 (10) 68 (12) 69 (12)
Total fibre (g/day) 19 (5) 18 (5) 23 (6) 22 (6)
Alcohol (g/day) 5 (7) 4 (7) 11 (13) 11 (13)
Total energy intake (kcal/day) 1767 (465) 1778 (473) 2000 (531) 1989 (534)
Red meat (servings/week) 4 (2) 4 (2) 4 (3) 4 (3)
Processed meat (servings/week) 2 (2) 2 (2) 2 (2) 2 (2)
History of sigmoidoscopy/colonoscopy 39 55 73 84
Family history of colorectal cancer 13 14 13 14
H2RA use 6 11 5 14
Regular aspirin use (≥2 tablets/week) 27 35 49 53
Regular NSAID use (≥2 tablets/week) 33 44 29 39
Multivitamin use 62 63 68 71
White 97 98 96 97
Menopausal hormone therapy use 40 48 N/A N/A
Postmenopausal status 55 59 N/A N/A
History of smoking
 Never 56 52 53 49
 Past 35 39 44 48
 Current 9 9 4 3

H2RA H2 receptor antagonist, MET metabolic equivalent, NSAID nonsteroidal anti-inflammatory drugs.

aAge-adjusted means (standard deviation) for continuous variables, and percentages for categorical variables.

bValues not age adjusted.